China CAS:1778-02-5 Manufacturer

August 2022
Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
99% manufactures meets the requirements of GMP.
Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

CPhI JAPAN 2025 will be held at East Halls 6, Tokyo Big Sight from April 09-11,2025, our booth number is 6C-20a.

CPHI Frankfurt 2025 will be held at Messe Frankfurt from October 28 to 30, our booth number is 12.1C3.

I've spent over twenty years working with companies like yours, and if there's one question I hear more than any other, it's this one. Selecting the right intermediates can feel like a high-stakes puzzle, where one wrong piece can impact your entire production line. It’s a decision that goes beyond mere cost; it's about partnership, reliability, and the integrity of your final product. In my journey, I've seen how a strategic partnership with a focused manufacturer like Humanwell Pharmaceutical can transform this challenging task from a source of anxiety into a competitive advantage. Let's break down the critical parameters you need to consider.

As someone who has spent over two decades navigating the complexities of industrial production, I've seen firsthand how bottlenecks in the middle stages can derail entire operations. That’s why I was particularly impressed when I began working with solutions from the Intermediates Category. For any production manager, finding tools that seamlessly integrate and accelerate the core of your workflow is the ultimate goal. This is where the strategic approach from Humanwell truly shines, offering a refined path to efficiency that many of us have been searching for.

Welcome to our booth at the upcoming exhibition for face-to-face communication.